Media Moguls has been appointed by NHS Blood and Transplant (NHSBT) to raise awareness about organ donation amongst South Asian and Black communities in the UK. Media Moguls is one of the UK's leading ethnic marketing agencies and previously designed and implemented the first ever South Asian Organ Donation campaign in 1998 - 2003 for the Department of Health. As well as increasing awareness about the lack of donors, the campaign also aims to challenge the misconceptions surrounding it. The campaign will support the decision-making process by providing accurate information and encouraging people to join the NHS Organ Donor Register. 23% of people currently waiting for a kidney transplant are from BME communities.
Medicare And The Mayo Clinic The Wall Street Journal [T]he real Mayo story is that sclerotic Medicare is preventing more Mayos, and ObamaCare is paving the way for all of health care to operate like Medicare (1/8). Ensuring Children's Health Care The San Jose Mercury News Californians need to ask themselves why, when other states and the federal government are making children's health a priority, the Golden State may be adding another half-million children ... to the ranks of the uninsured next year (1/7). Give These Donors A Bone The New York Times It would make sense to encourage [bone marrow] donation by offering potential donors an incentive - a gift to a favorite charity, for example, or a scholarship.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates. Those candidates exposed to the peer-based intervention (education) reported significantly greater knowledge, greater likelihood to discuss donation and increased self-efficacy compared to those not exposed to the intervention. Details of the study are reported in the January 2010 issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, published by Wiley-Blackwell.
More brain donors are needed to help research into Parkinson's disease says a leading UK charity, and younger donors especially. Last week the Parkinson's Disease Society revealed that a campaign earlier this year has helped to more than double the number of donors on the Parkinson's Brain Donor Register, but more brains are still needed. In April this year the Society ran a campaign that inspired more than 2, 300 people to join celebrities like Jane Asher, Jeremy Paxman and John Stapleton to sign up as donors and leave their brain to Parkinson's research when they die. They said that while the appeal was a huge success, there is still a need for additional donors, in particular younger people with Parkinson's.
NHS Blood and Transplant (NHSBT) urges UK citizens to make a positive, outward-looking resolution: join the NHS Organ Donor Register (ODR) and help make a real difference to the 10, 000 patients in the United Kingdom who need an organ transplant. Online and phone sign-ups to the ODR quadrupled 1 in November 2009 compared to the same month in 2008 - yet more must be done, with 3 people dying every day while they wait for an organ to become available. The most popular New Year resolutions are focused on self-improvement, and are often unfulfilled: to eat more fruit and vegetables, do more exercise, stop smoking, and drink less alcohol. 2 But we can do one very achievable simple thing focusing on saving the lives of others - join the NHS Organ Donor Register.
Life-Saving Therapeutic Interventions Possible with Early Detection of Hepatitis C Recurrence A recent study by doctors from the Hospital ClĂ nic in Barcelona, Spain determined that repeated liver stiffness measurements (LSM) in the first year following liver transplant (LT) could discriminate between slow and rapid "fibrosers" (patients with fibrosis stage of F2-F4 one year post LT). LSM were extremely accurate, particularly at the 6-month post LT point, in detecting severity of fibrosis. Determining those at risk for a recurrence of hepatitis C virus (HCV) allows for early-stage administration of therapies that could prevent LT or graft failure.